R, P., LJ, V., D, X., A, A., J, P., J, C., & MP, M. (2015). Phosphoproteomic Analysis of Cell-Based Resistance to BRAF Inhibitor Therapy in Melanoma. Frontiers in oncology, 5, 95. https://doi.org/10.3389/fonc.2015.00095
Chicago Style (17th ed.) CitationR, Parker, Vella LJ, Xavier D, Amirkhani A, Parker J, Cebon J, and Molloy MP. "Phosphoproteomic Analysis of Cell-Based Resistance to BRAF Inhibitor Therapy in Melanoma." Frontiers in Oncology 5 (2015): 95. https://doi.org/10.3389/fonc.2015.00095.
MLA (9th ed.) CitationR, Parker, et al. "Phosphoproteomic Analysis of Cell-Based Resistance to BRAF Inhibitor Therapy in Melanoma." Frontiers in Oncology, vol. 5, 2015, p. 95, https://doi.org/10.3389/fonc.2015.00095.
Warning: These citations may not always be 100% accurate.